3.94
전일 마감가:
$3.595
열려 있는:
$3.63
하루 거래량:
714.91K
Relative Volume:
1.08
시가총액:
$410.10M
수익:
$251.42M
순이익/손실:
$-202.39M
주가수익비율:
-2.2135
EPS:
-1.78
순현금흐름:
$38.21M
1주 성능:
+0.25%
1개월 성능:
+0.51%
6개월 성능:
-27.57%
1년 성능:
+1.03%
Definitive Healthcare Corp Stock (DH) Company Profile
명칭
Definitive Healthcare Corp
전화
508-720-4224
주소
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
DH을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
DH
Definitive Healthcare Corp
|
3.94 | 366.38M | 251.42M | -202.39M | 38.21M | -1.78 |
![]()
VEEV
Veeva Systems Inc
|
279.18 | 45.26B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
69.63 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
89.27 | 8.00B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.35 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
2025-01-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
2024-12-20 | 개시 | Stephens | Equal-Weight |
2024-09-17 | 개시 | BTIG Research | Buy |
2024-07-31 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2024-01-17 | 다운그레이드 | Needham | Buy → Hold |
2024-01-05 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2023-07-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2023-04-19 | 개시 | William Blair | Outperform |
2022-12-09 | 개시 | BofA Securities | Neutral |
2022-07-06 | 개시 | Needham | Buy |
2022-04-01 | 재개 | Credit Suisse | Neutral |
2022-02-24 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2021-12-16 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2021-12-02 | 개시 | Jefferies | Buy |
2021-11-17 | 개시 | Robert W. Baird | Outperform |
2021-10-11 | 개시 | Barclays | Equal Weight |
2021-10-11 | 개시 | Canaccord Genuity | Hold |
2021-10-11 | 개시 | Credit Suisse | Neutral |
2021-10-11 | 개시 | Deutsche Bank | Hold |
2021-10-11 | 개시 | Goldman | Neutral |
2021-10-11 | 개시 | JP Morgan | Neutral |
2021-10-11 | 개시 | Morgan Stanley | Equal-Weight |
2021-10-11 | 개시 | Raymond James | Mkt Perform |
2021-10-11 | 개시 | Stifel | Buy |
모두보기
Definitive Healthcare Corp 주식(DH)의 최신 뉴스
Definitive Healthcare’s Balanced Q2 2025 Earnings Call - MSN
Is Definitive Healthcare Corp. forming a reversal patternJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
Using data models to predict Definitive Healthcare Corp. stock movementGap Down & Free Real-Time Volume Trigger Notifications - Newser
Understanding Definitive Healthcare Corp.’s price movementDay Trading Setup and Momentum Analysis - Newser
Exit strategy if you’re trapped in Definitive Healthcare Corp.Free High Yield Stock Screening Results - Newser
Building trade automation scripts for Definitive Healthcare Corp.Technical Analysis of Growth Stock Opportunities - Newser
Custom strategy builders for tracking Definitive Healthcare Corp.Buy and Hold Strategy for Capital Safety - Newser
Definitive Healthcare Corp (DH) Stock: Navigating a Year of Volatility - investchronicle.com
Using Python tools to backtest Definitive Healthcare Corp. strategiesDay Trading Plan with Entry Risk Management - Newser
Comparing Definitive Healthcare Corp. in custom built stock radarsAI Trade Signal Forecast with Chart Logic - Newser
Is Definitive Healthcare Corp. a candidate for recovery playFree Swing Trading Plan With Smart Signals - Newser
What’s the recovery path for long term holders of Definitive Healthcare Corp.Buy Strategy with Smart Exit Timing - Newser
Sectors Driving Future Growth for Definitive Healthcare Corp. StockDaily Swing Candidate Analysis with Chart Patterns - Newser
Chart overlay techniques for tracking Definitive Healthcare Corp.Free Earnings Play Trade Plan With Alerts - Newser
Deutsche Bank Adjusts Definitive Healthcare Price Target to $5 From $4, Maintains Hold Rating - MarketScreener
Definitive Healthcare Corp: Hold Rating Amid Mixed Performance and Future Uncertainties - TipRanks
Can trapped investors hope for a rebound in Definitive Healthcare Corp.Free AI Powered High Return Stock Calls - Newser
Multi asset correlation models including Definitive Healthcare Corp.Capital Protection Strategy With Risk Analysis - Newser
Published on: 2025-08-11 00:06:40 - Newser
Developing predictive dashboards with Definitive Healthcare Corp. dataFree Secure Capital Picks With Upside Potential - Newser
Definitive Healthcare raises full-year revenue guidance to $237M-$240M driven by improved retention - MSN
Definitive Healthcare Corp. (NASDAQ:DH) Analysts Are Pretty Bullish On The Stock After Recent Results - 富途牛牛
Stifel Nicolaus Forecasts Strong Price Appreciation for Definitive Healthcare (NASDAQ:DH) Stock - Defense World
Why Definitive Healthcare Corp. stock is on top investor watchlistsFree Weekly Setup With 3x Return Potential - Newser
Is this a good reentry point in Definitive Healthcare Corp.Free Weekly Return Pick Forecast Reports - Newser
Definitive Healthcare Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Definitive Healthcare Corp. (NASDAQ:DH) Q2 2025 Earnings Call Transcript - Insider Monkey
Definitive Healthcare's Q2 2025 Earnings Call: Unpacking Contradictions in Sales Cycles, Customer Retention, and Market Demand - AInvest
Definitive Healthcare Corp. (DH) Q2 Earnings and Revenues Top Estimates - NewsBreak: Local News & Alerts
Definitive Healthcare price target raised to $4 from $3 at Baird - TipRanks
BofA Securities reiterates Buy rating on Definitive Healthcare stock By Investing.com - Investing.com Nigeria
Earnings call transcript: Definitive Healthcare Q2 2025 earnings beat forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Definitive Healthcare Q2 2025 earnings beat forecasts - Investing.com India
Stifel raises Definitive Healthcare stock price target to $6 on improved retention - Investing.com Nigeria
Cautious Optimism for Definitive Healthcare Corp Amid Market Strategy Revitalization and Customer Retention Challenges - TipRanks
Definitive Healthcare Q2 2025 slides: revenue decline continues but exceeds guidance - Investing.com
Definitive Healthcare Raises FY22 Revenue Guidance to $237M-$240M, Citing Improved Retention - AInvest
Definitive Healthcare Corp (DH) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Definitive Healthcare Exceeds Revenue Guidance, Cuts Net Loss in Q2 2025 - AInvest
Definitive Healthcare Reports Q2 2025 Results - TipRanks
Definitive Healthcare Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Why Definitive Healthcare Corp. stock attracts strong analyst attentionRisk Aware Swing Trade Analysis Insights - Newser
Definitive Healthcare Corp. shares rise 3.27% after-hours following Q2 revenue beat. - AInvest
Definitive Healthcare earnings beat by $0.02, revenue topped estimates - Investing.com
Detecting price anomalies in Definitive Healthcare Corp. with AIAI Powered Stock Market Trend Forecast - Newser
Definitive Healthcare Corp (DH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):